Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TU5R
|
|||
| Drug Name |
PMID29865878-Compound-49
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Proteasome beta-1 (PS beta-1) | Target Info | Inhibitor | [1] |
| Proteasome beta-5 (PS beta-5) | Target Info | Inhibitor | [1] | |
| Proteasome beta-8 (PS beta-8) | Target Info | Inhibitor | [1] | |
| Proteasome beta-9 (PS beta-9) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Proteasome beta-1 (PS beta-1) | Target's Patent Info | [1] | |
| Proteasome beta-5 (PS beta-5) | Target's Patent Info | [1] | ||
| Proteasome beta-8 (PS beta-8) | Target's Patent Info | [1] | ||
| Proteasome beta-9 (PS beta-9) | Target's Patent Info | [1] | ||
| KEGG Pathway | Proteasome | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A patent review of immunoproteasome inhibitors.Expert Opin Ther Pat. 2018 Jul;28(7):517-540. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.